205: What Makes AI Useful in Pathology Beyond the Demo?
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
-
Narrado por:
-
De:
Send us Fan Mail
What happens when AI looks strong in a paper, but the workflow still isn’t ready?
In DigiPath Digest #40, I reviewed five recent papers across kidney pathology, oral and maxillofacial pathology, glioma biomarker prediction, digital twins in neuro-oncology, and a major European colorectal cancer cohort. A common theme kept coming back: good performance is not the same thing as real-world readiness.
We started with kidney biopsies and the challenge of assessing interstitial fibrosis and tubular atrophy, where AI shows promise but still does not fully agree with humans. That led into a bigger point I keep seeing in digital pathology: our “ground truth” is often based on human interpretation, and human interpretation has variability too.
From there, I looked at AI in oral and maxillofacial pathology, where the field is still early and one major bottleneck is the lack of strong public datasets. Then I discussed a systematic review on adult-type gliomas showing that multimodal models performed better than unimodal ones, which makes sense when you think about how pathologists actually work: we do not diagnose from one input alone.
I also covered a systematic review on digital twins in neuro-oncology. The idea is exciting, but the paper makes it clear that reproducibility, public code, multimodal integration, and external validation are still limiting factors.
And finally, I talked about a paper I really liked: a large European colorectal cancer cohort built across 26 biobanks in 12 countries. That kind of harmonized, quality-checked dataset matters. A lot. Because better AI starts with better data.
In this episode, I discuss:
- Why AI vs human comparisons are harder than they first look
- the “gold standard paradox” in pathology
- Why multimodal AI keeps outperforming unimodal models
- What is holding digital twins back from broader use
- Why curated multicenter datasets are so important for digital pathology research
Resources mentioned:
- Digital Pathology 101 pdf copy
- Pathology AI Makeover Course
- DigiPath Digest AI-powered paper summaries
Papers discussed:
- https://pubmed.ncbi.nlm.nih.gov/41830415/
- https://pubmed.ncbi.nlm.nih.gov/41826004/
- https://pubmed.ncbi.nlm.nih.gov/41824546/
- https://pubmed.ncbi.nlm.nih.gov/41823607/
- https://pubmed.ncbi.nlm.nih.gov/41820399/
Support the show
Get the "Digital Pathology 101" FREE E-book and join us!